Clinical Trial Update: Pharmacogenetic Study for Topiramate-Induced Cognitive Dysfunction

View source ↗

Summary

This clinical trial update discusses a pharmacogenetic study assessing cognitive dysfunction potentially linked to topiramate exposure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Dysfunction

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Cognitive Dysfunction | Status: UNKNOWN